ESRX Express Scripts Holding Company (delisted)

Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2018 first quarter financial results on Wednesday, May 2, 2018, after the market closes. Management will not be holding a conference call to review results.   

A copy of the earnings release will be available at the Investor Information section of Express Scripts’ web site at http://www.express-scripts.com/corporate. 

About Express Scripts

Express Scripts puts medicine within reach by practicing pharmacy smarter – taking bold action, delivering specialized care, creating innovative solutions and leveraging data insights - to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services.  Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

Contact:                                                                       
Jim Havel, Chief Financial Officer                      
Ben Bier, Vice President Investor Relations                     
(314) 810-3115                                                          
investor.relations@express-scripts.com